Imagion Biosystems Ltd. · ASX:IBX
Imagion Biosystems — Shareholder Meeting (May 2024)
6 slides from Imagion Biosystems's shareholder meeting presentation, May 31, 2024
Slide 1: Changing the way we look at cancer
For personal use only Changing the way we look at cancer AGM Investor Presentation 31 May 2024 Imagion Biosystems Limited ImagionBiosystems.com ASX:IBX
Slide 2: Disclaimers
Disclaimers Imagionbiosystems.com This investor presentation (Presentation) has been prepared by Imagion Biosystems Limited (Imagion or the Company). This presentation does not constitute or form part of, and should not be construed as, an offer, solicitation or invitation to subscribe for, underwri
Slide 3: MagSense Imaging with MRI
MagSense Imaging with MRI ® Imagionbiosystems.com Changing the way we look at cancer Pre-Dose T2 For personal use only A Phase I study has been completed and the data indicate our molecularly targeted nanoparticles could be effective in detecting nodal disease in HER2 breast cancer patients when use
Slide 4: IMAGION 2.0
IMAGION 2.0 Imagionbiosystems.com Leaner and Restructured Value in our IP For personal use only • Outsource rather than build • MagSense® is a first-of-its-kind infrastructure; use consultants and technology to enable molecular MRI. contractors. • The “platform” has been demonstrated • Pay-as-you-go
Slide 5: The value in molecular MRI
The value in molecular MRI Imagionbiosystems.com MagSense® Technology Platform Strategic Partnerships For personal use only • HER2 breast cancer nodal detection is a • Big pharma and medical device US$200M market with standard of care companies routinely use M&A to build limited to detecting “suspic
Slide 6: www.imagionbiosystems.com
For personal use only www.imagionbiosystems.com info@imagionbio.com ASX:IBX